iBio, Inc. — Director's Dealing 2011

Apr 14, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: iBio, Inc. (IBIO)
CIK: 0001420720
Period of Report: 2011-04-12

Reporting Person: DESANTIS CARL (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-04-12	Common Stock	S	250000	$0.50	Disposed	5164541	Indirect

Footnotes

F1: Shares sold in a private transaction pursuant to a Stock Option Agreement originally entered into on May 21, 2010 with Kobus Investments, LLC and Biomed Investments, LLC, as described in detail in the Issuer's Registration Statement on Form S-3 filed with the SEC on March 14, 2011.

F2: Includes (i) 6,125 shares of common stock owned directly by the reporting person, (ii) 1,266,706 shares of common stock held by Integrated BioPharma, Inc., of which the reporting person is a controlling person, (iii) 1,406,293 shares of common stock held by CD Financial, LLC, (iv) 250,000 shares of common stock issuable upon exercise of a warrant held by CD Financial, LLC, and (v) 2,235,417 shares of common stock held by the DeSantis Revocable Trust.